Differential Regulation of the Melanoma Proteome by eIF4A1 and eIF4E.
Ontology highlight
ABSTRACT: Small molecules and antisense oligonucleotides that inhibit the translation initiation factors eIF4A1 and eIF4E have been explored as broad-based therapeutic agents for cancer treatment, based on the frequent upregulation of these two subunits of the eIF4F cap-binding complex in many cancer cells. Here, we provide support for these therapeutic approaches with mechanistic studies of eIF4F-driven tumor progression in a preclinical model of melanoma. Silencing eIF4A1 or eIF4E decreases melanoma proliferation and invasion. There were common effects on the level of cell-cycle proteins that could explain the antiproliferative effects in vitro Using clinical specimens, we correlate the common cell-cycle targets of eIF4A1 and eIF4E with patient survival. Finally, comparative proteomic and transcri
SUBMITTER: Joyce CE
PROVIDER: S-EPMC5362820 | biostudies-literature | 2017 Feb
REPOSITORIES: biostudies-literature
ACCESS DATA